TNF and COVID-19: Also, in agreement with our results, obtained results from Lanzoni et al. study revealed that intravenous transplantation of UC-MSCs in two different doses could significantly decrease the inflammatory cytokine (TNF-α) and increase the anti-inflammatory cytokine (IL-10) in COVID-19-induced ARDS patients [21].